All News

Regulatory & Standards

FDA Accept BLA Application for Iovance Biotherapeutic’s Advanced Melanoma Cell Therapy
31 May 2023
FDA Accept BLA Application for Iovance Biotherapeutic’s Advanced Melanoma Cell Therapy
Biotechnology Company Iovance Biotherapeutics has
First Bladder Cancer Patients Dosed in Protara Therapeutics Phase Ib Trial
16 May 2023
First Bladder Cancer Patients Dosed in Protara Therapeutics Phase Ib Trial
Clinical-stage developer of cancer and
FDA Vote in Favor of Accelerating Approval of Gene Therapy for Duchenne Muscular Dystrophy
16 May 2023
FDA Vote in Favor of Accelerating Approval of Gene Therapy for Duchenne Muscular Dystrophy
Leader in precision genetic medicine
Ready for Market – How Do We Get ATMPs Over the Line in Europe?
12 May 2023
Ready for Market – How Do We Get ATMPs Over the Line in Europe?
Join us as a panel
POPULAR NEWS ITEMS
Image
8 June 2023

Eureka Therapeutics Awarded $10.6M CIRM Grant for T-Cell Therapy in Pediatric Liver Cancer

Image
7 June 2023

Cell and Gene Therapy Catapult Open New Edinburgh, UK, Facilities

Image
5 June 2023

BioCentriq® Unveils LEAP™ Advanced Therapy Platform, Enabling Rapid Patient Access for Early-Stage Biotech Companies

Cell and Gene Challenges with AGC Biologics
20 March 2023
Cell and Gene Challenges with AGC Biologics
Maggie Chen, Head of Manufacturing
Autologous vs Allogeneic: What Therapeutic Developers and Manufacturers Really Need to Know
16 March 2023
Autologous vs Allogeneic: What Therapeutic Developers and Manufacturers Really Need to Know
Rupa Pike, Senior Director of
Adaptimmune and TCR2 Collaborate to Develop Cell Therapies for Solid Tumors
8 March 2023
Adaptimmune and TCR2 Collaborate to Develop Cell Therapies for Solid Tumors
Adaptimmune Theraputics and TCR2 Theraputics
Mesoblast Phase III Cell Therapy Shows Promise Against Heart Failure  
28 February 2023
Mesoblast Phase III Cell Therapy Shows Promise Against Heart Failure  
Mesoblast has announced that the
Load more News
RECOMENDED TOPICS
Clinical Trials
Collaborations, Mergers & Acquisitions
Finance & Investment
Patient Access & Engagement
Regulatory & Standards
Reimbursement
Strategy
POPULAR NEWS ITEMS
Image

Eureka Therapeutics Awarded $10.6M CIRM Grant for T-Cell Therapy in Pediatric Liver Cancer

Image

Cell and Gene Therapy Catapult Open New Edinburgh, UK, Facilities

Image

BioCentriq® Unveils LEAP™ Advanced Therapy Platform, Enabling Rapid Patient Access for Early-Stage Biotech Companies